title: Octreotide for recurrent intestinal bleeding due to ventricular assist device.
abstract: We report the case of a 64-year-old Jarvik 2000 recipient with a high risk of bleeding (anticoagulation treatment and acquired von Willebrand disease), who presented with intractable gastrointestinal hemorrhage due to severe gastric angiodysplasia. He was successfully treated with long-acting octreotide.
authors.affiliation: Department of Cardiology, University Hospital Center-Caen, Caen, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Coutance
authors.forename: Vladimir
authors.initials: V
authors.lastname: Saplacan
authors.forename: Annette
authors.initials: A
authors.lastname: Belin
authors.forename: Yohann
authors.initials: Y
authors.lastname: Repessé
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Buklas
authors.forename: Massimo
authors.initials: M
authors.lastname: Massetti
mesh_terms: D016888:Angiodysplasia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006333:Heart Failure / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006353:Heart-Assist Devices / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D011474:Prosthesis Design; D012008:Recurrence; D013272:Stomach Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D016277:Ventricular Function, Left; D014842:von Willebrand Diseases / Q000209:etiology
chemical_list: D000925:Anticoagulants; D005765:Gastrointestinal Agents; D015282:Octreotide
keywords: Angiodysplasia; gastrointestinal hemorrhage; heart-assist devices; octreotide